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Theﬁrstmaturecells toariseinthedevelopingmammalianembryobelongtotheerythroidlineage. Thishighlightstheimmediacy
of the need for red blood cells during embryogenesis and for survival. Linked with this pressure is the necessity of the embryo to
obtain and transport iron, synthesize hemoglobin, and then dispose of the potentially toxic heme via the stress-induced protein
heme oxygenase-1 (HO-1, encoded by Hmox1 in the mouse). Null mutation of Hmox1 results in signiﬁcant embryonic mortality
as well as anemia and defective iron recycling. Here, we discuss the interrelated nature of this critical enzyme with iron traﬃcking,
erythroid cell function, and embryonic survival.
1. Iron,Heme, andHemoglobin
Adult humans require 4-5mg of iron per day [1]. The
predominant use of iron is in its reduced ferrous state
(Fe2+) in heme complexed with two α-globin and two β-
globin chains to form hemoglobin. Reduced iron in heme is
uniquely amenable for the transport of oxygen and carbon
monoxide, while hemoglobin can also bind allosteric ligands
such as carbon dioxide and nitric oxide. When red blood
cells are lysed, iron in the released hemoglobin can become
oxidized to its ferric (Fe3+) form, and heme no longer
binds tightly to hemoglobin and may be released [2, 3].
The hydrophobicity of the resulting free heme allows it to
cross cell membranes leading to oxidative stress within cells
[4, 5]. If left uncontrolled, heme and its iron can contribute
to the cellular labile iron pool and act as a pro-oxidant by
catalytically amplifying the production of oxidants inside
the cell via Fenton chemistry whereby Fe2+ is oxidized by
hydrogen peroxide to Fe3+, a hydroxyl radical, and hydroxyl
anion. Ampliﬁcation of oxidant production by redox-active
iron can directly lead to lipid, protein, and DNA damage
and ultimately cell death. However, free iron can be rapidly
neutralized by a number of metabolic pathways induced by
the iron itself. These include the induction of iron eﬄux
systems or upregulation of ferritin, a cytosolic protein that
sequesters iron in a redox-inactive form, thereby limiting its
pro-oxidant capacity. Free heme has also been shown to have
proinﬂammatory properties. With the vast amount of heme
used in erythroid cells, mechanisms must be put into place
to allow the body to cope with free iron and heme released
during red blood cell clearance in the spleen.
2.Heme Catabolism
Heme oxygenases are the initial and rate-limiting enzymes
in the breakdown of heme (iron protoporphyrin IX) that
itself plays an essential role in the transport of oxygen
and mitochondrial electron transport as a cofactor of
hemoglobin, myoglobin, and cytochromes. Degradation of
heme generates carbon monoxide, iron, and biliverdin,
the latter of which is subsequently converted to bilirubin
by biliverdin reductase (Figure 1). Heme oxygenases bind
heme in a 1:1 molar complex where turnover of each
heme molecule requires three molecules of O2 and seven
electrons derived from NADPH supplied by cytochrome
P450 reductase. Heme oxygenases are unusual in their ability
to use heme both as a substrate and prosthetic group
for its own degradation. However, heme oxygenases are2 Advances in Hematology
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Figure 1: Heme catabolism initiated by heme oxygenases. Heme
oxygenase-1 and 2 (HO-1/2) degrade heme to carbon monoxide
(CO), Fe2+, and biliverdin that is then reduced to bilirubin by
biliverdin reductase (BVR).
not heme proteins in the classic sense of the cytochromes
or peroxidases [6]. The removal of toxic heme is not
the only function of heme oxygenases, as the products
of their enzymatic activity have now being recognized to
play signiﬁcant roles in vascular biology, iron recycling,
and cellular protection against oxidative stress and diseases
associated with such stress [7, 8].
Heme oxygenases are evolutionarily conserved, and
various forms can be detected in bacteria, plants, fungi,
and animals indicating that the need for heme degradation
occurred early during evolution. A heme oxygenase “ﬁn-
gerprint” motif has been used to identify heme-degrading
enzymes from a range of organisms. Bacterial and human
heme oxygenases show up to 70% homology within this
motif [9]. There are two distinct isoforms of heme oxy-
genase, the inducible heme oxygenase-1 (HO-1) and a
constitutively expressed form, HO-2 [10]. HO-1 and HO-
2 are the products of diﬀerent genes, and the amino acid
sequences of the human HO-1 and HO-2 isoforms show
∼42%sequencehomology[11].Whilebothisoformsrequire
similar substrates and cofactors for heme oxidation, the
kinetics of the enzymatic reaction diﬀers with the Km value
for heme being three times higher for HO-2 than HO-1.
HO-1 is a 32-kDa protein also known as heat shock
and stress response protein HSP32. HO-1 is an early stress
response gene and the predominant heme oxygenase species
present in the spleen under physiological conditions [11].
High levels of HO-1 are detected in tissues that degrade aged
red blood cells such as the specialized reticuloendothelial
cellsofthespleen,liver,andbonemarrow[7].Inmosttissues
not directly involved in erythrocyte or hemoglobin turnover,
HO-1 is generally not detected. However, a diverse range of
chemical and physical stresses and treatments, such as heme,
cytokines, lipopolysaccharide, growth factors, heat shock,
hydrogen peroxide, and heavy metals, rapidly induce HO-
1. This induction is believed to indicate a critical adaptive
response to cellular stress.
HO-1 localizes to the ER, anchored there by a single
hydrophobic transmembrane spanning region at the C-
terminal domain. HO-1 localizes in close proximity to
NADPH cytochrome P450 reductase which is required for
maximal enzymatic activity [12]. However, recently HO-
1 has been demonstrated to localize to other subcellular
organelles including the plasma membrane, mitochondria,
and the nucleus [13, 14]. While the biological implications
of this sub-cellular compartmentalization have not been
fully elucidated, it raises the possibility of organelle-speciﬁc
function of HO-1 and its metabolites [12].
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Figure 2: Distinct waves of erythroid cell generation in the mouse.
Diﬀerent populations of erythroid cells are generated during
distinct embryonic periods in the bone marrow and following
injury in the mouse. These populations vary according to their
site of origin, embryonic stage of production, morphology, and
β-globin gene expression. E: embryonic day, scored from days
following coitus.
3. Erythropoiesis throughout Life
The erythroid or red blood cell lineage is the main consumer
of iron and heme in the human body. This lineage is also the
ﬁrst cell type to mature during mammalian embryogenesis
[15]. In mice, at least ﬁve distinct forms of erythropoiesis,
or red blood cell production, have been identiﬁed (Figure 2).
The erythrocytes produced during these distinct waves may
vary according to cell size and globin gene expression proﬁle,
but all serve to transport oxygen and metabolic waste
products via hemoglobin. Systems regulating both heme
production and catabolism are, therefore, required from
early embryonic development and throughout adulthood to
prevent the release of free heme and subsequent oxidative
stress.
The ﬁrst erythroid population to arise is the primitive
erythroidlineage[16].Theseredbloodcellsareupto6-times
larger than their adult counterparts and express a unique
set of globin genes only activated during embryogenesis
[15, 17]. These cells are generated in the extraembryonic
yolk sac, dominate the embryonic circulation, but are almost
undetectable by birth [17, 18]. The yolk sac is also the source
of another, recently identiﬁed erythroid population which
express a mixture of embryonic and adult-type globin genes
andarethoughttopopulate thefetalliver[19].Thefetalliver
itself gives rise to a third distinct population which expresses
only adult-type globin genes. Shortly before birth, the bone
marrow becomes the predominant site of life-long blood cell
production. These erythrocytes express adult globin genes
only and are slightly smaller than those produced by the
fetal liver. An auxiliary wave of erythropoiesis is generated
following stress, such as signiﬁcant blood loss or ongoing
erythroid disease such as sickle cell anemia or β-thalassemia.
Thiswaveis termedstresserythropoiesis and is characterized
by migration of immature erythroblasts from the bone
marrowtothespleen[20].RegulationofstresserythropoiesisAdvances in Hematology 3
is a research area that has only recently obtained some of
the interest it warrants, and the processes regulating this
phenomenon are ill deﬁned.
4. Macrophage Function during the Erythroid
CellLifecycle
Macrophages play crucial roles in erythropoiesis from the
cradle of the bone marrow to the grave of the spleen.
In erythropoietic tissues, such as the fetal liver and bone
marrow, erythroblasts are found in intimate proximity to
supportive macrophages in multicellular structures termed
erythroblastic islands (EBIs) [21]. These structures are
thought to play crucial roles in regulating erythroid cell
production with a central macrophage often interacting
with numerous erythroblasts [22]. Central EBI macrophages
have been postulated to transfer iron to the developing
erythroblasts to complete hemoglobin synthesis. This idea is
strengthened by the initial description of EBI macrophages
as containing iron detected by Perls’ staining [21]. However,
developing erythroblasts also express high levels of the
transferrin receptor, CD71, demonstrating the vast appetite
for iron that these cells have [23, 24].
Central EBI macrophages are critical for the engulfment
and destruction of the vast numbers of erythroid cell nuclei
that are expelled in the ﬁnal stages of red blood cell
maturation. Evidence for the uptake of expelled erythroid
nuclei comes from several sources. Fluorescently tagged,
p r i m i t i v ee r y t h r o i dn u c l e ih a v eb e e no b s e r v e de n g u l f e db y
fetal liver macrophages [25]. Secondly, null mutation of
DNAse II, the major DNA-degrading enzyme present in
macrophages, results in the massive buildup of erythroid
nucleiwithinthecytoplasmicoffetallivermacrophages[26].
As DNAse II-deﬁcient macrophages are unable to degrade
erythroid DNA, these phagocytes swell from engulfed nuclei,
rupture, and release inﬂammatory mediators into the fetal
liver killing the embryo in utero [26].
Macrophagesalsoplayacriticalroleattheendoftheery-
throcytelifespan.Agedordamagederythrocytesareremoved
from the circulation by macrophages found in the red pulp
of the spleen. Macrophages recognise aged erythrocytes by
increased expression of surface phosphatidylserine and by
decreased levels of the “self” antigen CD47 [27, 28]. Indeed,
one of the chief roles of splenic macrophages is to engulf
and destroy aged or damaged erythrocytes, catabolize the
heme from the hemoglobin, and return the free iron to the
developing erythroblasts of the bone marrow via transferrin
[1].
5. The Impact of HO-1 Deﬁciency in
Mice andHumans
Heme oxygenase-1-deﬁcient mice have been generated by
targeted null mutation of the Hmox1 gene. The original
authors, other groups, and our own group (unpublished
data) have noticed abnormally low number of Hmox1−/−
mice at birth, strongly suggesting that the Hmox1 deﬁciency
is lethal in a signiﬁcant number of embryos [29, 30].
Approximately 20% of the expected number of Hmox1−/−
pups are born live [29]. The infrequent Hmox1−/− animals
that survive until adulthood are smaller in size compared
with their littermate wild-type mice and exhibit a range
of pathological conditions including splenic, hepatic, and
renal ﬁbrosis as well as increased expression of indicators
of stress and inﬂammation [31]. Accumulation of iron is
observed in tissues throughout the body of Hmox1−/− mice,
strongly suggesting that these animals suﬀer from defects in
the traﬃcking of iron from peripheral tissues back to sites of
erythropoiesis [32].
Hemeoxygenase-1deﬁciencyinhumansappearstobean
extremely rare condition with only two live births reported
[33,34].Bothpatientspresentedwithsevereanemia[33,34].
The patient reported in Japan showed a high degree of ery-
throcyte fragmentation as well as high serum concentrations
of heme, iron deposition, and a striking absence of a spleen
[33]. This latter condition was distinct from the phenotype
seen in adult Hmox1−/− mice, which exhibit enlarged spleens
[29]. As heme is a potent inducer of oxidative stress, it
has been postulated that most of the pathophysiological
conditions observed in these extremely rare individuals,
including hyperlipidemia, vascular disease, and renal
injury, are due to the inability to rid the body of heme
[35].
6. Heme Oxygenase-1 andEmbryonic Survival
Embryonic survival appears to be linked to HO-1 gene
dosage. The mother of the Japanese HO-1-deﬁcient patient
was found to be heterozygous for Hmox1 and had experi-
enced several fetal deaths [33]. Supporting this, polymor-
phisms in the human HMOX1 gene have been associated
with an increased risk for idiopathic recurrent miscarriage
[36]. HO-1 is expressed widely throughout the placenta
includingthesyncytiotrophoblastsandendothelialcells[37].
Carbon monoxide produced locally by heme catabolism by
HO-1 is thought to contribute to the regulation of vascular
tone within the placenta. HO-1 expression is also thought
to stimulate trophoblast invasion into the placenta [38]. To
investigatepossibleplacentationdefects,Zhaoandcolleagues
examined Hmox1+/− embryos and found that their placentae
were reduced in weight [30].Thiswasattributedtoapoptosis
in the spongiotrophoblast layer. HO-1 expression during
ontogeny has been examined in the rat, where the enzyme
is expressed in the syncytiotrophoblasts of the placenta as
well as the endodermal layer of the yolk sac [39]. Expression
was also detected in immature macrophages in the yolk sac
and later in macrophages in the fetal liver [39]. Similarly,
during the ﬁrst 48 hours of development of the zebra ﬁsh
embryo, Hmox1 mRNA was detected in yolk syncytial layer,
blood cells, as well as the lens [40]. Hmox1 deﬁciency
may, therefore, aﬀect development of the mouse yolk sac
through changes in the endoderm, as well as resulting in
macrophage defects. Collectively, these data implicate roles
for HO-1 in placenta formation, development of the yolk
sac, and function of macrophages in the embryo itself.
Interferencewithanyofthesedevelopmentalstepscouldlead
to embryonic lethality.4 Advances in Hematology
7. Heme Oxygenase-1 andHematopoiesis
The spleen encounters the greatest amount of heme, arising
from the clearance of aged or damaged erythrocytes by
r e dp u l pm a c r o p h a g e s .S p l e e n sf r o mHmox1−/− mice are
enlarged and show decreased amounts of free iron, as
assessed by Perls Prussian blue staining [32]. Macrophages
isolated from such spleens are reduced in number and
show intoxication from heme. These macrophages are able
t oe n g u l fa n dd e s t r o ya g e do rd a m a g e dr e db l o o dc e l l s .
However, they fail to detoxify the heme released from the
breakdown of the engulfed erythrocytes due to the lack of
Hmox1 [32]. This is thought to lead to macrophage death
and splenomegaly. Spleens from Hmox1−/− mice are also
highly ﬁbrotic, again a defect most likely associated with
the lack of macrophages. This results in profound changes
in iron recycling. In the wild-type setting, macrophages in
the spleen and liver are the main iron traﬃcking cells. In
the absence of HO-1, proteins that serve to sequester free
hemoglobin and heme (i.e., haptoglobin and hemopexin,
resp.) are elevated in the liver and kidney [32]. In the case
of haptoglobin, this may be a consequence of the drastic
decrease in the expression of CD163, the scavenger receptor
that normally removes haptoglobin-hemoglobin complexes
from the circulation [32]. Instead, hepatocytes and the
proximal tubular epithelial cells of the kidney become the
predominant cell types regulating the reutilization of iron
derived from erythrocytes in HO-1−/− mice, likely relying
on the enzymatic activity of HO-2 [32]. This suggests that
compensatory pathways are enhanced in the absence of the
main system to detoxify the body of heme.
Hmox1 gene dosage has been implicated in the response
ofthehematopoieticsystemtostress. Hmox1+/− micetreated
with the hematopoietic toxin 5-ﬂuorouracil showed a more
rapid recovery in blood cell counts compared with wild-type
mice [41]. However, this response to stress was not observed
during transplantation assays where hematopoietic stem
cells from Hmox1+/− mice poorly reconstituted irradiated
adult host animals and failed to give rise to serially trans-
plantable hematopoietic stem cells [41] .T h es a m eg r o u p
also found that irradiated adult mice, reconstituted with
Hmox1+/− bone marrow cells, showed signiﬁcant defects in
the traﬃcking of erythroblasts to the spleen. While this is a
relatively artiﬁcial stress model, these results do suggest that
erythroblasts migrating from the bone marrow to the spleen
may be inﬂuenced by Hmox1 gene dosage [42].
8. UnresolvedIssues
Oneofthemostintriguing questionsinthisﬁeldiswhymost
Hmox1−/− embryos die in utero while a small fraction are
born live and can survive until late adulthood? Knockout
mice lacking genes essential for erythropoiesis are often
100% embryonic lethal (e.g., all Eklf-deﬁcient embryos die
in utero [43]) or survive until adulthood with milder defects.
A phenotype resulting in most embryos dying in utero with a
small percentage surviving until late adulthood is, therefore,
highly unusual. The fact that a small number of Hmox1−/−
mice and HO-1-deﬁcient individuals are born live suggests
that mechanisms, such as genetic or environmental modi-
ﬁers, can rescue these defects suﬃciently to allow survival
until birth. Is the lethality seen in HO-1 knockout embryo
due to death of macrophages intoxicated by heme they are
unable to catabolize following engulfment of embryonic
erythroid cells? Or is HO-1 playing a more important role
in epithelial cells such as the syncytiotrophoblasts or visceral
endoderm of the yolk sac? Alternatively, environmental
factors derived from the mother may somehow rescue this
typically lethal phenotype. Resolving these modiﬁers will
shed light onto the function of HO-1. A clear reason for the
survival of a fraction of the HO-1−/− mice to birth and even
one year of age, while others die in utero, is still not readily
apparent.
9. Concluding Remarks
During evolution, the utility of both iron and heme has
been harnessed to drive basic biochemical activities within
our cells. Erythroid cells, in particular, have used these com-
pounds extremely eﬀectively to transport gases throughout
ourbodies.However,thisisadouble-edgedswordasthevery
activities that make iron and heme useful are the same that
makethempotentiallytoxictoourcells.HO-1isessentialfor
amelioratingitstoxicity.Thisishighlightedbytheembryonic
lethality of HO-1 deﬁciency. The activity of this enzyme
is, therefore, a critical tipping point between health and
anemia or embryonic death. Increasing our knowledge of
the roles of HO-1 in embryonic development may provide a
better understanding of how the enzyme provides protection
against oxidative stress-associated diseases.
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